A study published in the Canadian Journal of Public Health has found that immigrants to Canada have fewer non-food allergies than the non-immigrant population, but that the difference diminishes with longer duration of residence in Canada. The study, which is …
The majority of Canadian chiropractic, naturopathic, homeopathic and acupuncture clinics claim that they can diagnose or treat allergy/sensitivity and asthma, according to an AllerGen study of nearly 400 clinic websites. The research, published December 17, 2016, in BMJ Open, analyzed …
Canadian alternative medicine clinics: over half make unproven allergy/asthma claims Read More »
AllerGen is pleased to announce that Dr. Catherine Biggs has been awarded the prestigious AllerGen Emerging Clinician-Scientist Research Fellowship. During the two-year Fellowship, Dr. Biggs will train under the supervision of AllerGen investigator Dr. Stuart Turvey, pediatric immunologist and director …
AllerGen awards fourth Emerging Clinician-Scientist Research Fellowship Read More »
On November 30, 2016, the US National Academies of Sciences, Engineering and Medicine (Health & Medicine Division) released a major report on food allergies: Finding a Path to Safety in Food Allergy: Assessment of the Global Burden, Causes, Prevention, Management, …
New Food Allergy Report from the US National Academies Read More »
Dr. Randy Yatscoff, a key member of the AllerGen network since 2010, has been awarded the Startup Canada Adam Chowaniec Lifetime Achievement Award. The award is presented to an individual who has demonstrated an “outstanding impact and enduring legacy” in …
Randy Yatscoff wins lifetime achievement award for Canadian entrepreneurship Read More »
A new study by researchers in AllerGen’s Clinical Investigator Collaborative (CIC) has shown that a developmental drug, QGE031 (ligelizumab), is three times more effective than Xolair (omalizumab) in reducing symptoms of mild allergic asthma. The research, led by Dr. Gail …
CIC researchers find new drug more effective than Xolair Read More »
An early career researcher and former AllerGen Network trainee has been named a 2016 Banting Postdoctoral Fellow. The fellowship, valued at $70,000 per year for two years, is Canada’s most prestigious award for postdoctoral research. Dr. Matthew Gold, a Postdoctoral …
AllerGen trainee receives prestigious Banting Postdoctoral Fellowship Read More »
AllerGen Research Leader Dr. John Gordon and his team at the University of Saskatchewan have developed a new immunotherapy technique that reverses food allergies in mice. Their research was co-funded by AllerGen and CIHR. The findings, published in the Journal …
Immunotherapy technique holds promise for curing food allergies Read More »
A new study by AllerGen researchers suggests that nearly 18% of children who are treated medically for an anaphylactic reaction will experience another episode of anaphylaxis within a year. The study also found that children with food-induced anaphylaxis and children …
Anaphylaxis recurrence in kids: New C-CARE findings Read More »
Two AllerGen investigators were honoured at the Awards Dinner of the 2016 Canadian Society of Allergy and Clinical Immunology (CSACI) Annual Scientific Meeting held September 29 – October 2, 2016, in Montreal, QC. Dr. Bruce Mazer (McGill University) received the …
An animated musical about the harmful chemicals contained in plastic consumer products took first place in AllerGen’s 2016 HQP Video Competition. “The Phthalates Song,” created by Evelyn Gunawan, Min Hyung Ryu and Agnes Yuen, received top ranking from an expert …
Winning HQP videos “clever” and “relatable,” say judges Read More »
AllerGen Research Leader Dr. Jeffrey Brook is Scientific Director and Nominated-Principal Investigator on a new five-year, $4.16 million Operating Grant from the CIHR’s Environments and Health Signature Initiative. The project, CANadian Urban Environmental (CANUE) Health Research Consortium, aims to advance …
AllerGen Research Leader heads major urban health project Read More »